COMP <GO>
MEDP vs UNH // REVENUE GROWTH (YOY)
Medpace Holdings Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: MEDP 6
— UNH 8
▲ REVENUE GROWTH (YOY) LEADER: MEDP
LAST: $652.01 (-3.77%) • MKT CAP: $18.95B
revenue-growth
20.00%
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
revenue-growth
6.46%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MEDP VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MEDP | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 88.57% | -47.57 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 27.90% | 11.47% | +16.43 | MEDP | /roic <GO> |
| EV/EBITDA & P/E Valuation | 34.0x | 16.4x | +17.55 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 3.60% | 6.48% | -2.88 | UNH | /fcf-yield <GO> |
| Operating Margin | 21.10% | 4.82% | +16.28 | MEDP | /operating-margins <GO> |
| Net Profit Margin | 17.80% | 3.14% | +14.66 | MEDP | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 20.00% | 6.46% | +13.54 | MEDP | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.13 | 3.12 | +6.01 | MEDP | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 6.74% | +0.16 | UNH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.6 | 56.0 | -1.43 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.00 | 0.33 | +0.67 | MEDP | /macro-sensitivity <GO> |
| Forward P/E Multiple | 35.3x | 17.1x | +18.21 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $18.95B | $364.66B | -$345.71B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MEDP REV | UNH REV | MEDP GROSS % | UNH GROSS % | MEDP FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.53B | $447.57B | 44.0% | 88.7% | $681.9M | $16.07B |
| FY 2024 | $2.11B | $400.28B | 44.0% | 88.3% | $572.3M | $20.70B |
| FY 2023 | $1.89B | $371.62B | 44.0% | 89.6% | $348.5M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MEDP // BETA 1.00
UNH // BETA 0.33